NYSE:TBI - Trueblue Stock Price, Price Target & More

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Trueblue declared that its board has approved a stock buyback plan on Tuesday, October 31st 2017, which allows the company to repurchase $100,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's management believes its stock is undervalued.

Trueblue Inc (NYSE:TBI) posted its quarterly earnings data on Monday, April, 30th. The business services provider reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.09. The business services provider earned $554.39 million during the quarter, compared to analysts' expectations of $570.40 million. Trueblue had a net margin of 2.39% and a return on equity of 13.81%. The company's revenue was down 2.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.21 earnings per share. View Trueblue's Earnings History.

Trueblue is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Trueblue.

Trueblue issued an update on its second quarter earnings guidance on Monday, April, 30th. The company provided earnings per share guidance of $0.47-0.53 for the period, compared to the Thomson Reuters consensus estimate of $0.53. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $627.25 million.

2 Wall Street analysts have issued 1 year price targets for Trueblue's shares. Their predictions range from $26.00 to $29.00. On average, they anticipate Trueblue's stock price to reach $27.50 in the next twelve months. This suggests that the stock has a possible downside of 0.4%. View Analyst Ratings for Trueblue.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trueblue in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Trueblue include ASGN (ASGN), Insperity (NSP), Dometic Group AB (publ) (DTCGF), AMN Healthcare Services (AMN), TTEC (TTEC), Kforce (KFRC), Kelly Services, Inc. Class A (KELYA), Kelly Services, Inc. Class B (KELYB), Barrett Business Services (BBSI), SThree (STREF), Cross Country Healthcare (CCRN), StarTek (SRT), DLH (DLHC), R C M Technologies (RCMT) and Hudson Global (HSON).

News headlines about TBI stock have trended somewhat positive on Saturday, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Trueblue earned a media sentiment score of 0.11 on Accern's scale. They also gave media headlines about the business services provider an impact score of 45.11 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Trueblue's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include James Investment Research Inc. (0.36%), Bank of Montreal Can (0.29%), Municipal Employees Retirement System of Michigan (0.05%), Alpha Windward LLC (0.05%) and Cornerstone Wealth Management LLC (0.03%). Company insiders that own Trueblue stock include Bonnie W Soodik, Derrek Lane Gafford, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Institutional Ownership Trends for Trueblue.

TBI stock was sold by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan and Bank of Montreal Can. Company insiders that have sold Trueblue company stock in the last year include Bonnie W Soodik, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Insider Buying and Selling for Trueblue.

TBI stock was bought by a variety of institutional investors in the last quarter, including James Investment Research Inc., Cornerstone Wealth Management LLC and Alpha Windward LLC. View Insider Buying and Selling for Trueblue.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $27.60.

Trueblue has a market capitalization of $1.16 billion and generates $2.51 billion in revenue each year. The business services provider earns $55.45 million in net income (profit) each year or $1.74 on an earnings per share basis. Trueblue employs 5,500 workers across the globe.

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]